首页> 外文期刊>Scandinavian journal of gastroenterology. >Nasobiliary drainage can reduce the incidence of post-ERCP pancreatitis after papillary large balloon dilation plus endoscopic biliary sphincterotomy: a randomized controlled trial
【24h】

Nasobiliary drainage can reduce the incidence of post-ERCP pancreatitis after papillary large balloon dilation plus endoscopic biliary sphincterotomy: a randomized controlled trial

机译:鼻梭菌排水可以减少乳头状大球体扩张后ERCP后胰腺炎的发生率加上内镜胆道椎间露特异性:随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background and aims: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis can be reduced following endoscopic papillary balloon dilation with the placement of an endoscopic nasobiliary drainage (ENBD) catheter. The aim of this study was to determine whether the placement of an ENBD reduces the risk of post-ERCP pancreatitis following endoscopic papillary large balloon dilation together with endoscopic biliary sphincterotomy.Methods: A total of 160 patients with bile duct stones were randomly assigned (1:1) to an ENBD group or no-ENBD group. The primary outcome of this study was the incidence of post-ERCP pancreatitis. The secondary outcome was the incidence of post-ERCP hyperamylasemia.Results: In total, 160 patients were randomized, and 155 were found to be eligible for the analysis. The two groups were similar regarding clinical and demographic factors as well as patient- and procedure-related risk factors for post-ERCP pancreatitis. Post-ERCP pancreatitis developed in 9 patients, that is, 8/77 (10.4%) of the control group and 1/78 (1.28%) of the ENBD group (p=.018; per protocol analysis). Intention to treat analysis also revealed that ENBD reduced the rate of post-ERCP pancreatitis (8/80 (10%) in the control group vs. 1/80 (1.25%) the ENBD group (p=.034)). Multivariate regression analysis identified not undergoing ENBD as an independent risk factor for post-ERCP pancreatitis (ENBD compared with no-ENBD: OR 0.087, 95% CI 0.011-0.734; p=.025).Conclusion: This study demonstrated that placement of an ENBD was effective and safe for the prevention of post-ERCP pancreatitis in patients undergoing endoscopic papillary large balloon dilation together with endoscopic biliary sphincterotomy.
机译:背景和目的:后内窥镜逆行胆管胰岛素(ERCP)胰腺炎可以在内窥镜乳头状球囊扩张后的放置内窥镜鼻梭菌引流(ENBD)导管。本研究的目的是确定enbd的安置是否降低了ERCP胰腺炎后内镜乳头状大球体扩张后的风险。方法:随机分配了总共160例胆管结石(1 :1)到enbd组或无en-enbd组。本研究的主要结果是ERCP后胰腺炎的发生率。二次结果是后ERCP高亚亚亚血症的发生率两组与临床和人口统计因子相似,以及ERCP后胰腺炎的患者和程序相关的危险因素。 ERCP后胰腺炎在9名患者中,即对照组的8/77(10.4%)和1/78(1.28%)的enbd组(P = .018;每个协议分析)。治疗分析的意图还显示enbd降低了ERCP后胰腺炎的速率(对照组的8/80(10%),与1/80(1.25%)enbd组(P = .034))。多变量回归分析未被接受ENBD作为ERCP后胰腺炎的独立危险因素(与NO-ENBD相比:0.087,95%CI 0.011-0.734; P = .025)。结论:本研究表明,放置了一个enbd在接受内镜乳头大球扩张的患者与内镜胆道括约肌切开术中,预防ERCP后胰腺炎是有效和安全的。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号